SE455503B - Karbostyrilderivat och framstellning och farmaceutisk kompostion derav - Google Patents
Karbostyrilderivat och framstellning och farmaceutisk kompostion deravInfo
- Publication number
- SE455503B SE455503B SE8304737A SE8304737A SE455503B SE 455503 B SE455503 B SE 455503B SE 8304737 A SE8304737 A SE 8304737A SE 8304737 A SE8304737 A SE 8304737A SE 455503 B SE455503 B SE 455503B
- Authority
- SE
- Sweden
- Prior art keywords
- group
- formula
- defined above
- same
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15409082A JPS5962585A (ja) | 1982-09-03 | 1982-09-03 | カルボスチリル誘導体 |
| JP57213167A JPS59104378A (ja) | 1982-12-03 | 1982-12-03 | カルボスチリル誘導体 |
| JP58114679A JPS606685A (ja) | 1983-06-24 | 1983-06-24 | カルボスチリル誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8304737D0 SE8304737D0 (sv) | 1983-09-02 |
| SE8304737L SE8304737L (sv) | 1984-03-04 |
| SE455503B true SE455503B (sv) | 1988-07-18 |
Family
ID=27312797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8304737A SE455503B (sv) | 1982-09-03 | 1983-09-02 | Karbostyrilderivat och framstellning och farmaceutisk kompostion derav |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4564619A (es) |
| KR (1) | KR910000181B1 (es) |
| CA (1) | CA1252469A (es) |
| CH (1) | CH655110A5 (es) |
| DE (1) | DE3331808A1 (es) |
| ES (4) | ES8502686A1 (es) |
| FR (1) | FR2532648B1 (es) |
| GB (1) | GB2127402B (es) |
| IT (1) | IT1193145B (es) |
| NL (1) | NL8303066A (es) |
| SE (1) | SE455503B (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT80533B (en) * | 1984-05-29 | 1987-04-06 | Pfizer | Process for preparing quinolone inotropic agents |
| GB8529362D0 (en) * | 1985-11-28 | 1986-01-02 | Pfizer Ltd | Quinolone cardiac stimulants |
| DK167187A (da) * | 1986-04-02 | 1987-10-03 | Otsuka Pharma Co Ltd | Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse |
| KR940000785B1 (ko) * | 1986-04-02 | 1994-01-31 | 오오쓰까세이야꾸 가부시끼가이샤 | 카르보스티릴 유도체 및 그의 염의 제조 방법 |
| KR100305515B1 (ko) * | 1999-02-04 | 2001-09-24 | 이순금 | 메주의 제조방법 |
| NL1012886C1 (nl) | 1999-08-23 | 2001-02-26 | Rephartox | 1,4-Dihydropyridine-5-carbonzuuresterderivaten en werkwijze voor de bereiding ervan. |
| KR100422242B1 (ko) * | 2001-07-20 | 2004-03-12 | 농업회사법인(주)맛가마식품 | 중공봉형상 메주와 이를 이용한 간장 및 된장 제조방법과제조용 장독 |
| US20070066619A1 (en) * | 2002-10-07 | 2007-03-22 | Artesian Therapeutics, Inc. | Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| PL376405A1 (en) * | 2002-10-07 | 2005-12-27 | Artesian Therapeutics, Inc. | Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| NL1028564C2 (nl) * | 2005-03-17 | 2006-09-20 | Rademaker Holding B V | Toepassing van een coumarine-groep omvattende derivaten voor de bereiding van een antiviraal middel, coumarine-group omvattende derivaten, een werkwijze voor de bereiding daarvan, en farmaceutische preparaten die deze bevatten. |
| EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス，インコーポレイティド | Ｐｄｅ阻害による神経新生の調節 |
| CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| AU2007223036A1 (en) * | 2006-03-08 | 2007-09-13 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| US20100216734A1 (en) * | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| AU2007249435A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
| WO2007134136A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| KR20090064418A (ko) * | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| WO2008036678A2 (en) * | 2006-09-19 | 2008-03-27 | Braincells, Inc. | Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| US20150119399A1 (en) | 2012-01-10 | 2015-04-30 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3971797A (en) * | 1973-06-15 | 1976-07-27 | Merck & Co., Inc. | S,S'-bis(pyridylmethyl)-carbonodithioates |
| DE2508181A1 (de) * | 1975-02-26 | 1976-09-09 | Bayer Ag | 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| US4081447A (en) * | 1975-04-09 | 1978-03-28 | Abbott Laboratories | 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof |
| DE2659665A1 (de) * | 1976-12-30 | 1978-07-13 | Nattermann A & Cie | Neue 1,4-dihydropyridin-derivate |
| JPS5387368A (en) * | 1977-01-12 | 1978-08-01 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
| JPS5390270A (en) * | 1977-01-14 | 1978-08-08 | Otsuka Pharmaceut Co Ltd | Carbostryl derivs. |
| IE46852B1 (en) * | 1977-06-10 | 1983-10-05 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives |
| DE2805404A1 (de) * | 1978-02-09 | 1979-08-16 | Merck Patent Gmbh | 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung |
| IT1097538B (it) * | 1978-07-17 | 1985-08-31 | Medea Res Srl | Processo per la preparazione del 2,6-dimetil-4-3(3-nitrofenil)-3-metossicarbonil-1,4-didropiridin-5-carbossilati di 2(n-benzil-n-metilammino) |
| CA1117117A (en) * | 1978-10-10 | 1982-01-26 | Fujisawa Pharmaceutical Co., Ltd. | 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same |
| DE3034237A1 (de) * | 1979-09-18 | 1981-04-16 | Otsuka Pharmaceutical Co. Ltd., Tokyo | Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel |
| PH17194A (en) * | 1980-03-06 | 1984-06-19 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives,and pharmaceutical composition containing the same |
| JPS5777676A (en) * | 1980-10-31 | 1982-05-15 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
| JPS57200386A (en) * | 1981-06-04 | 1982-12-08 | Yoshitomi Pharmaceut Ind Ltd | Novel 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its salts |
-
1983
- 1983-09-01 CH CH4807/83A patent/CH655110A5/de not_active IP Right Cessation
- 1983-09-02 SE SE8304737A patent/SE455503B/sv not_active IP Right Cessation
- 1983-09-02 ES ES525346A patent/ES8502686A1/es not_active Expired
- 1983-09-02 DE DE19833331808 patent/DE3331808A1/de not_active Withdrawn
- 1983-09-02 US US06/528,887 patent/US4564619A/en not_active Expired - Fee Related
- 1983-09-02 KR KR1019830004144A patent/KR910000181B1/ko not_active IP Right Cessation
- 1983-09-02 NL NL8303066A patent/NL8303066A/nl not_active Application Discontinuation
- 1983-09-02 CA CA000435962A patent/CA1252469A/en not_active Expired
- 1983-09-02 FR FR8314115A patent/FR2532648B1/fr not_active Expired
- 1983-09-02 GB GB08323542A patent/GB2127402B/en not_active Expired
- 1983-09-05 IT IT67922/83A patent/IT1193145B/it active
-
1984
- 1984-05-16 ES ES532538A patent/ES532538A0/es active Granted
- 1984-05-16 ES ES532536A patent/ES8505998A1/es not_active Expired
- 1984-05-16 ES ES532537A patent/ES8601187A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| KR850000402A (ko) | 1985-02-27 |
| NL8303066A (nl) | 1984-04-02 |
| FR2532648A1 (fr) | 1984-03-09 |
| ES8506697A1 (es) | 1985-07-16 |
| ES525346A0 (es) | 1985-01-16 |
| CH655110A5 (de) | 1986-03-27 |
| CA1252469A (en) | 1989-04-11 |
| ES532537A0 (es) | 1985-10-16 |
| GB8323542D0 (en) | 1983-10-05 |
| GB2127402A (en) | 1984-04-11 |
| ES8601187A1 (es) | 1985-10-16 |
| ES532538A0 (es) | 1985-07-16 |
| SE8304737D0 (sv) | 1983-09-02 |
| KR910000181B1 (ko) | 1991-01-21 |
| FR2532648B1 (fr) | 1989-07-21 |
| US4564619A (en) | 1986-01-14 |
| ES532536A0 (es) | 1985-06-16 |
| ES8502686A1 (es) | 1985-01-16 |
| GB2127402B (en) | 1987-01-14 |
| IT8367922A0 (it) | 1983-09-05 |
| ES8505998A1 (es) | 1985-06-16 |
| DE3331808A1 (de) | 1984-03-08 |
| SE8304737L (sv) | 1984-03-04 |
| IT1193145B (it) | 1988-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE455503B (sv) | Karbostyrilderivat och framstellning och farmaceutisk kompostion derav | |
| EP2855467B1 (en) | Processes to produce certain 2-(pyridine-3-yl)thiazoles | |
| EP0389861B1 (en) | Benzopyran derivatives and processes for preparation thereof | |
| EP0456835B1 (en) | Quinazoline-3-alkanoic acid derivative, salt thereof, and production thereof | |
| JPS62240680A (ja) | ２−アゾリルメチル−２−アリ−ル−１，３−ジオキソランおよびその製法 | |
| NO144514B (no) | Skaftbefestigelse for husholdnings- og haveredskaper | |
| US4703051A (en) | 4,7-dihydrothieno[2,3-B]pyridine derivatives useful in the treatment of cardiovascular diseases | |
| JPS60126270A (ja) | カルボスチリル誘導体 | |
| EP0618206A1 (en) | Pharmaceutical compounds | |
| EP0294695A2 (en) | New polyoxygenated labdane derivatives, a process for their preparation, and their use as medicaments | |
| DK147159B (da) | Analogifremgangsmaade til fremstilling af et glycerolderivat | |
| KR900004923B1 (ko) | 1,4-디히드로피리딘 유도체의 제조방법 | |
| US4737506A (en) | Anti-arteriosclerotic pyridyl or imidazolyl derivatives of carbonyloxyalkyl hantzsch esters | |
| EP0140327B1 (en) | Bis-dioxopiperazine derivatives, process for their preparation, antitumor agents comprising them and compositions containing them | |
| EP0188803B1 (en) | Piperazine derivative | |
| JPS63150266A (ja) | ベンジルイミダゾ−ル誘導体 | |
| EP0033214A2 (en) | Process for preparing therapeutically active triazoles | |
| JP3897473B2 (ja) | １，４−ジヒドロピリジン誘導体 | |
| EP0427860A1 (en) | New imidazole derivatives, production thereof, and uses thereof as medicines | |
| US4459407A (en) | 1-(4-Aminobenzyl)-2,3-dioxopiperazine derivatives and salts thereof | |
| JPH068252B2 (ja) | 降圧剤 | |
| JPH0374226B2 (es) | ||
| JPH0480884B2 (es) | ||
| US3264323A (en) | Coumarin derivative | |
| CA1080223A (en) | 1,4-dihydropyridine derivatives, process for preparation thereof and pharmaceutical composition of the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 8304737-3 Effective date: 19940410 Format of ref document f/p: F |